Trial · NCT04049097
Adverse events27
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 27
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Contusion | Injury, poisoning and procedural complications | Arimoclomol (Open-label) | 7 | 121 | 9 |
| other | Transaminases increased | Investigations | Arimoclomol (Open-label) | 10 | 121 | 10 |
| other | Aspartate aminotransferase increased | Investigations | Arimoclomol (Open-label) | 13 | 121 | 13 |
| other | Blood lactate dehydrogenase increased | Investigations | Arimoclomol (Open-label) | 7 | 121 | 7 |
| other | Gamma-glutamyltransferase increased | Investigations | Arimoclomol (Open-label) | 10 | 121 | 11 |
| other | Alanine aminotransferase increased | Investigations | Arimoclomol (Open-label) | 14 | 121 | 14 |
| other | Diarrhoea | Gastrointestinal disorders | Arimoclomol (Open-label) | 13 | 121 | 15 |
| other | Constipation | Gastrointestinal disorders | Arimoclomol (Open-label) | 15 | 121 | 15 |
| other | Abdominal discomfort | Gastrointestinal disorders | Arimoclomol (Open-label) | 7 | 121 | 7 |
| other | Insomnia | Psychiatric disorders | Arimoclomol (Open-label) | 9 | 121 | 9 |
| other | Nausea | Gastrointestinal disorders | Arimoclomol (Open-label) | 8 | 121 | 10 |
| serious | Corona virus infection | Infections and infestations | Arimoclomol (Open-label) | 2 | 121 | 2 |
| serious | Pneumonia | Infections and infestations | Arimoclomol (Open-label) | 1 | 121 | 1 |
| serious | Transaminases increased | Investigations | Arimoclomol (Open-label) | 2 | 121 | 2 |
| serious | Electrocardiogram abnormal | Investigations | Arimoclomol (Open-label) | 1 | 121 | 1 |
| serious | B-cell lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Arimoclomol (Open-label) | 1 | 121 | 1 |
| serious | Intraductal proliferative breast lesion | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Arimoclomol (Open-label) | 1 | 121 | 1 |
| serious | Prostate cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Arimoclomol (Open-label) | 1 | 121 | 1 |
| serious | Crohn's disease | Gastrointestinal disorders | Arimoclomol (Open-label) | 1 | 121 | 1 |
| serious | Large intestine perforation | Gastrointestinal disorders | Arimoclomol (Open-label) | 1 | 121 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04049097/events